Merit Medical Systems, Inc. (MMSI)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$89.60+1.16%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · MMSI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 1,578.8 | 1,515.9 | 1,356.5 | 1,257.4 | 1,151.0 | 1,074.8 | 963.9 | 994.9 | 882.8 | 727.9 | 603.8 | 542.1 | 509.7 | 449.0 | 394.3 | 359.4 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 359.4 |
| Cost of Revenues | 797.1 | 777.6 | 713.2 | 673.5 | 631.9 | 589.4 | 562.7 | 562.5 | 488.0 | — | — | — | — | — | — | — |
| Gross Profit | 781.7 | 738.3 | 643.3 | 583.9 | 519.1 | 485.3 | 401.2 | 432.4 | 394.8 | 326.3 | 265.0 | 235.8 | 225.2 | 194.4 | 182.0 | 165.5 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 482.1 | 455.2 | 399.7 | 373.7 | 342.5 | 335.7 | 297.7 | 327.3 | 276.0 | 229.1 | 184.4 | 156.3 | 147.9 | 128.6 | 122.1 | 104.5 |
| R&D Expenses | — | — | — | — | — | — | — | — | 59.5 | 51.4 | 45.2 | 40.8 | 36.6 | 33.9 | 27.8 | 21.9 |
| Operating Income | 201.4 | 184.7 | 155.7 | 123.9 | 87.6 | 60.9 | (1.6) | 15.4 | 58.6 | 33.1 | 34.9 | 37.5 | 40.2 | 27.8 | 29.6 | 33.2 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 26.5 | 31.2 | 15.5 | 6.3 | 5.3 | 10.0 | 12.4 | 10.4 | 7.7 | 8.8 | 6.2 | 8.8 | 8.0 | 0.6 | 0.8 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | 1.2 | 0.4 | 0.1 | 0.3 | 0.2 | 0.3 | 0.2 | 0.1 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | 9.2 | 7.4 | 8.7 | 6.0 | 8.6 | 7.8 | 0.4 | 0.7 |
| Other Non-Operating Income / Expenses | (6.9) | (13.8) | (5.7) | (11.9) | (4.9) | (7.0) | (11.7) | (13.2) | (9.1) | 2.8 | (9.5) | (6.3) | (8.6) | (8.0) | (2.0) | (0.3) |
| Asset Writedown | — | — | — | 0.3 | 2.2 | 4.3 | 36.5 | 23.8 | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 194.5 | 170.9 | 150.0 | 112.1 | 82.6 | 53.9 | (13.2) | 2.2 | 49.5 | 35.9 | 25.4 | 31.2 | 31.6 | 19.8 | 27.6 | 32.9 |
| Income Tax Expense | 48.9 | 42.4 | 29.6 | 17.7 | 8.1 | 5.5 | (3.4) | (3.3) | 7.5 | 8.4 | 5.3 | 7.4 | 8.6 | 3.3 | 7.9 | 9.8 |
| Net Income | ||||||||||||||||
| Net Income | 145.6 | 128.5 | 120.4 | 94.4 | 74.5 | 48.5 | (9.8) | 5.5 | 42.0 | 27.5 | 20.1 | 23.8 | 23.0 | 16.6 | 19.7 | 23.0 |
| Per Share | ||||||||||||||||
| Basic EPS | 2.44 | 2.17 | 2.07 | 1.64 | 1.31 | 0.86 | (0.18) | 0.10 | 0.80 | 0.56 | 0.45 | 0.54 | 0.53 | 0.39 | 0.47 | 0.59 |
| Diluted EPS | 2.43 | 2.13 | 2.03 | 1.62 | 1.29 | 0.84 | (0.18) | 0.10 | 0.78 | 0.55 | 0.45 | 0.53 | 0.53 | 0.39 | 0.46 | 0.58 |
| Revenue per Share | 26.31 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 59.7 | 59.2 | 58.2 | 57.6 | 56.8 | 56.1 | 55.4 | 55.1 | 52.3 | 48.8 | 44.4 | 44.0 | 43.1 | 42.6 | 42.2 | 39.1 |
| Diluted Weighted Avg Shares | 60.0 | 60.5 | 59.4 | 58.4 | 57.7 | 57.4 | 55.4 | 56.2 | 53.9 | 50.1 | 44.9 | 44.5 | 43.4 | 42.9 | 42.6 | 39.7 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 307.9 | 258.4 | 213.9 | 169.4 | 145.0 | 92.5 | 107.5 | 128.2 | 86.7 | 78.6 | 75.0 | 76.1 | 60.4 | 52.2 | 52.4 |
| EBIT | 201.4 | 184.7 | 155.7 | 123.9 | 87.6 | 60.9 | (1.6) | 15.4 | 58.6 | 33.1 | 34.9 | 37.5 | 40.2 | 27.8 | 29.6 | 33.2 |
| Effective Tax Rate | 25.1% | — | — | 15.8% | 9.8% | 10.1% | 25.6% | -148.6% | 15.1% | 23.3% | 20.7% | 23.7% | 27.2% | 16.5% | 28.6% | 29.9% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.